Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Lorlatinib (Standard); HY-12215R
Summary PubChem Same Compound
1454846-35-5; 2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-
Lorlatinib; 1454846-35-5; (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile
Lorlatinib; 1454846-35-5
1454846-35-5; (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetraazatetracyclo[16.3.1.0(2),?.0(1)?,(1)?]docosa-1(21),2,5,10(15),11,13,18(22),19-octaene-3-carbonitrile
Lorlatinib; 1454846-35-5; PF06463922 ...
Lorlatinib; Loratinib; Lorviqua ...
Lorlatinib
NCGC00386417-15
Summary PubChem Same Compound Tested in 4 BioAssays
1454846-35-5; PF06463922(Lorlatinib)
1454846-35-5; Lorlatinib (PF-06463922)
Lorlatinib; 1454846-35-5; DTXSID201027944
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on